Bloomberg – A cyberattack that US natural gas pipeline owners weren’t required to report has lawmakers taking a closer look at how the industry is handling such threats, raising the prospect of tighter regulation.
USA TODAY – A former high school football player who has been left with lifelong debilitating effects precipitated by an in-game injury and his coaching staff’s inability to correctly diagnose that he had suffered a concussion was handed a whopping $7.1 million settlement.
Autoblog – The White House intends to nominate a top auto-safety agency official to run the National Highway Traffic Safety Administration as regulators deal with contentious issues such as autonomous vehicles.
STAT – Surgeon General Jerome Adams is issuing a rare public health advisory, calling for friends and family of people at risk for opioid overdoses to carry the OD-reversal medication naloxone.
USA TODAY – The sound of spring is changing in Florida. Yes, there are still plenty of bats and baseballs hitting gloves, but the whistles and cheers are often focused on another sport: girls flag football.
Los Angeles Times – On a 4-3 vote, the state's highest court refused to throw out that part of the Proposition 69, which has led to the storing of DNA profiles of tens of thousands of people arrested but never charged or convicted.
The New York Times – Tesla’s semiautonomous driving system is coming under new scrutiny after the company disclosed late on Friday that a fatal crash on March 23 in California occurred while Autopilot was engaged.
MIT Technology Review – In a big win for the biotech industry, the US Department of Agriculture says it won’t regulate plants whose genomes have been altered using gene-editing technology.
Reuters – The family of a woman killed by an Uber Technologies Inc self-driving vehicle in Arizona has reached a settlement with the ride services company, ending a potential legal battle over the first fatality caused by an autonomous vehicle.
The Scientist – A newly passed law in Texas known as “Charlie’s Law” could allow Texas clinics to administer certain non-FDA-approved stem cell treatments to select patients.